We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · June 18, 2022

Humoral Response to SARS-CoV-2 Vaccines in Patients With MS

Multiple Sclerosis and Related Disorders


Additional Info

Multiple Sclerosis and Related Disorders
The humoral response to SARS-COV-2 vaccines in MS patients: A case series exploring the impact of DMT, lymphocyte count, immunoglobulins, and vaccine type
Mult Scler Relat Disord 2022 May 01;61(2022)103785, C Jakubecz, XS Zhang, S Woodson, A Serra, H Abboud

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading